Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen
复制标题
DOI:
10.1086/422756
复制
发表时间:
2004-09-01
影响因子:
6.4
通讯作者:
Clemens, JD
中科院分区:
文献类型:
--
作者:
Lin, FYC;Weisman, LE;Clemens, JD
The present study estimates the level of maternal immunoglobulin (Ig) G anti-group B streptococcus (GBS) type III required to protect neonates against early-onset disease (EOD) caused by this pathogen. Levels of maternal serum IgG anti-GBS type III, measured by enzyme-linked immunosorbent assay, in 26 case patients ( neonates with EOD caused by GBS type III) and greater than or equal to43 matched control subjects ( neonates colonized by GBS type III who did not develop EOD) of greater than or equal to 34 weeks gestation were compared. The probability of EOD decreased with increasing levels of maternal IgG anti-GBS type III (P = .01). Neonates whose mothers had greater than or equal to10 mug/mL IgG anti-GBS type III had a 91% lower risk for EOD, compared with those whose mothers had levels of = 10 mu g/mL in mothers can be predicted to offer a significant degree of protection against EOD caused by this pathogen.